Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

13
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (13)

Searched Name

Kevin F. Gilbert

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Roecker AJ, Mercer SP, Bergman JM, Gilbert KF, Kuduk SD, Harrell CM, Garson SL, Fox SV, Gotter AL, Tannenbaum PL, Prueksaritanont T, Cabalu TD, Cui D, Lemaire W, Winrow CJ, Renger JJ, Coleman PJ. Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements. Bioorg Med Chem Lett 2015;25:4992-4999. [DOI: 10.1016/j.bmcl.2014.12.081] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2014] [Revised: 12/22/2014] [Accepted: 12/24/2014] [Indexed: 01/25/2023]

Rudd MT, Butcher JW, Nguyen KT, McIntyre CJ, Romano JJ, Gilbert KF, Bush KJ, Liverton NJ, Holloway MK, Harper S, Ferrara M, DiFilippo M, Summa V, Swestock J, Fritzen J, Carroll SS, Burlein C, DiMuzio JM, Gates A, Graham DJ, Huang Q, McClain S, McHale C, Stahlhut MW, Black S, Chase R, Soriano A, Fandozzi CM, Taylor A, Trainor N, Olsen DB, Coleman PJ, Ludmerer SW, McCauley JA. P2-quinazolinones and bis-macrocycles as new templates for next-generation hepatitis C virus NS3/4a protease inhibitors: discovery of MK-2748 and MK-6325. ChemMedChem 2015;10:727-35. [PMID: 25759009 DOI: 10.1002/cmdc.201402558] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2014] [Indexed: 12/11/2022]

Rudd MT, McCauley JA, Romano JJ, Butcher JW, Bush K, McIntyre CJ, Nguyen KT, Gilbert KF, Lyle TA, Holloway MK, Wan BL, Vacca JP, Summa V, Harper S, Rowley M, Carroll SS, Burlein C, DiMuzio JM, Gates A, Graham DJ, Huang Q, Ludmerer SW, McClain S, McHale C, Stahlhut M, Fandozzi C, Taylor A, Trainor N, Olsen DB, Liverton NJ. Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease. Bioorg Med Chem Lett 2012;22:7201-6. [DOI: 10.1016/j.bmcl.2012.08.106] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2012] [Revised: 08/27/2012] [Accepted: 08/28/2012] [Indexed: 10/27/2022]

Rudd MT, McIntyre CJ, Romano JJ, Butcher JW, Holloway MK, Bush K, Nguyen KT, Gilbert KF, Lyle TA, Liverton NJ, Wan BL, Summa V, Harper S, Rowley M, Vacca JP, Carroll SS, Burlein C, DiMuzio JM, Gates A, Graham DJ, Huang Q, Ludmerer SW, McClain S, McHale C, Stahlhut M, Fandozzi C, Taylor A, Trainor N, Olsen DB, McCauley JA. Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2–P4 linkers. Bioorg Med Chem Lett 2012;22:7207-13. [DOI: 10.1016/j.bmcl.2012.09.061] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2012] [Revised: 09/05/2012] [Accepted: 09/17/2012] [Indexed: 10/27/2022]

Harper S, McCauley JA, Rudd MT, Ferrara M, DiFilippo M, Crescenzi B, Koch U, Petrocchi A, Holloway MK, Butcher JW, Romano JJ, Bush KJ, Gilbert KF, McIntyre CJ, Nguyen KT, Nizi E, Carroll SS, Ludmerer SW, Burlein C, DiMuzio JM, Graham DJ, McHale CM, Stahlhut MW, Olsen DB, Monteagudo E, Cianetti S, Giuliano C, Pucci V, Trainor N, Fandozzi CM, Rowley M, Coleman PJ, Vacca JP, Summa V, Liverton NJ. Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor. ACS Med Chem Lett 2012;3:332-6. [PMID: 24900473 DOI: 10.1021/ml300017p] [Citation(s) in RCA: 138] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2012] [Accepted: 02/26/2012] [Indexed: 11/29/2022] Open

Affiliation(s)

Steven Harper Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
John A. McCauley Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Michael T. Rudd Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Marco Ferrara Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Marcello DiFilippo Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Benedetta Crescenzi Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Uwe Koch Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Alessia Petrocchi Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
M. Katharine Holloway Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
John W. Butcher Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Joseph J. Romano Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Kimberly J. Bush Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Kevin F. Gilbert Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Charles J. McIntyre Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Kevin T. Nguyen Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Emanuela Nizi Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Steven S. Carroll Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Steven W. Ludmerer Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Christine Burlein Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Jillian M. DiMuzio Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Donald J. Graham Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Carolyn M. McHale Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Mark W. Stahlhut Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
David B. Olsen Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Edith Monteagudo Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Simona Cianetti Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Claudio Giuliano Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Vincenzo Pucci Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Nicole Trainor Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Christine M. Fandozzi Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Michael Rowley Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Paul J. Coleman Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Joseph P. Vacca Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Vincenzo Summa Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy
Nigel J. Liverton Departments of †Medicinal Chemistry, ‡Antiviral Research, §Drug Metabolism, and ∥Chemistry, Modeling and Informatics, Merck Research Laboratories, West Point, Pennsylvania 19486, United States Departments of ⊥Medicinal Chemistry, #Drug Metabolism, and ∇Molecular Modeling, IRBM, Merck Research Laboratories, Rome, Italy

Collapse

Rudd MT, McCauley JA, Butcher JW, Romano JJ, McIntyre CJ, Nguyen KT, Gilbert KF, Bush KJ, Holloway MK, Swestock J, Wan BL, Carroll SS, DiMuzio JM, Graham DJ, Ludmerer SW, Stahlhut MW, Fandozzi CM, Trainor N, Olsen DB, Vacca JP, Liverton NJ. Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure. ACS Med Chem Lett 2011;2:207-12. [PMID: 24900304 DOI: 10.1021/ml1002426] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2010] [Accepted: 12/24/2010] [Indexed: 01/09/2023] Open

Affiliation(s)

Michael T. Rudd Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
John A. McCauley Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
John W. Butcher Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Joseph J. Romano Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Charles J. McIntyre Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Kevin T. Nguyen Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Kevin F. Gilbert Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Kimberly J. Bush Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
M. Katharine Holloway Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
John Swestock Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Bang-Lin Wan Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Steven S. Carroll Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Jillian M. DiMuzio Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Donald J. Graham Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Steven W. Ludmerer Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Mark W. Stahlhut Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Christine M. Fandozzi Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Nicole Trainor Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
David B. Olsen Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Joseph P. Vacca Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States
Nigel J. Liverton Departments of Medicinal Chemistry, ‡Molecular Systems, §Antiviral Research, and ∥Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania 19486, United States

Collapse

McCauley JA, McIntyre CJ, Rudd MT, Nguyen KT, Romano JJ, Butcher JW, Gilbert KF, Bush KJ, Holloway MK, Swestock J, Wan BL, Carroll SS, DiMuzio JM, Graham DJ, Ludmerer SW, Mao SS, Stahlhut MW, Fandozzi CM, Trainor N, Olsen DB, Vacca JP, Liverton NJ. Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor. J Med Chem 2010;53:2443-63. [DOI: 10.1021/jm9015526] [Citation(s) in RCA: 147] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]

Liverton NJ, Holloway MK, McCauley JA, Rudd MT, Butcher JW, Carroll SS, DiMuzio J, Fandozzi C, Gilbert KF, Mao SS, McIntyre CJ, Nguyen KT, Romano JJ, Stahlhut M, Wan BL, Olsen DB, Vacca JP. Molecular Modeling Based Approach to Potent P2−P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease. J Am Chem Soc 2008;130:4607-9. [PMID: 18338894 DOI: 10.1021/ja711120r] [Citation(s) in RCA: 94] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]

Affiliation(s)

Nigel J. Liverton Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
M. Katharine Holloway Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
John A. McCauley Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Michael T. Rudd Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
John W. Butcher Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Steven S. Carroll Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Jillian DiMuzio Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Christine Fandozzi Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Kevin F. Gilbert Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Shi-Shan Mao Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Charles J. McIntyre Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Kevin T. Nguyen Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Joseph J. Romano Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Mark Stahlhut Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Bang-Lin Wan Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
David B. Olsen Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486
Joseph P. Vacca Departments of Medicinal Chemistry, Antiviral Research, Drug Metabolism, and Molecular Systems, Merck Research Laboratories, West Point, Pennsylvania 19486

Collapse

Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C. In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia. J Med Chem 2000;43:2703-18. [PMID: 10893308 DOI: 10.1021/jm990612y] [Citation(s) in RCA: 177] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Moon Kim B, Evans BE, Gilbert KF, Hanifin CM, Vacca JP, Michelson SR, Darke PL, Zugay JA, Emini EA, Schleif W, Lin JH, Chen IW, Vastag K, Anderson PS, Huff JR. Cycloalkylpiperazines as HIV-1 protease inhibitors: enhanced oral absorption. Bioorg Med Chem Lett 1995. [DOI: 10.1016/0960-894x(95)00461-2] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]

Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Garsky VM, Gilbert KF, Leighton JL, Carson KL, Mellin EC. Development of 1,4-benzodiazepine cholecystokinin type B antagonists. J Med Chem 1993;36:4276-92. [PMID: 8277510 DOI: 10.1021/jm00078a018] [Citation(s) in RCA: 51] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]

Evans BE, Lundell GF, Gilbert KF, Bock MG, Rittle KE, Carroll LA, Williams PD, Pawluczyk JM, Leighton JL, Young MB. Nanomolar-affinity, non-peptide oxytocin receptor antagonists. J Med Chem 1993;36:3993-4005. [PMID: 8258821 DOI: 10.1021/jm00077a002] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]

Evans BE, Leighton JL, Rittle KE, Gilbert KF, Lundell GF, Gould NP, Hobbs DW, DiPardo RM, Veber DF, Pettibone DJ. Orally active, nonpeptide oxytocin antagonists. J Med Chem 1992;35:3919-27. [PMID: 1331449 DOI: 10.1021/jm00099a020] [Citation(s) in RCA: 74] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]